4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001209191-22-021051
Chief Financial Officer bought 7,500 shares at $1.09 ($8,174)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David Chief Financial Officer | 2022-03-24 | Purchase | +7,500 | $1.09 | $8,174 | 21,896 | D: show line 1 in the form |
| Open-market purchases · 7,500 sh · avg $1.09 · $8,174 | |||||||
Loading xslF345X03/doc4.xml…